Status:

COMPLETED

Comparison Bioavailability Study of Quinine Sulfate in Chocolate Pudding

Lead Sponsor:

Mutual Pharmaceutical Company, Inc.

Conditions:

Healthy

Eligibility:

All Genders

18-50 years

Phase:

PHASE1

Brief Summary

This is an open label randomized single dose two-way crossover study to compare the bioavailability of a single oral dose of quinine sulfate 648 mg(2 x 324 mg) when mixed with 120 ml of chocolate pudd...

Detailed Description

Prior studies have shown that intact quinine sulfate capsules can be taken without regard for food. This is an open label randomized single dose two-way crossover study to compare the bioavailability ...

Eligibility Criteria

Inclusion

  • Healthy nonsmoking adults with hemoglobin at least 12 g/dl. Males at least 52 kg, females at least 45kg with body mass index in the normal range, females must be chemically or surgically sterile or postmenopausal (amenorrhea at least 2years)

Exclusion

  • Pregnant or lactating
  • Test positive at screening for human immunodeficiency virus (HIV), hepatitis B surface antigen (HbsAg), or hepatitis C virus (HCV) Recent (1-year) history or evidence of alcoholism or drug abuse History or presence of significant cardiovascular, pulmonary, hepatic, renal, hematological, gastrointestinal, endocrine, immunologic, dermatologic, neurological, or psychiatric disease, myasthenia gravis, optic neuritis or Glucose-6-phosphate dehydrogenase (G6PD) deficiency
  • Prolonged corrected QT interval(QTc) on Electrocardiogram(EKG) at screening -males \>430 msec, females \>450 msec.
  • PR interval on EKG \>200 msec at screening or prior to dose in either dosing period
  • Subjects who have used any drugs or substances known to inhibit or induce cytochrome (CYP) P450 enzymes and/or P-glycoprotein (P-gp) within 30 days prior to the first dose and throughout the study

Key Trial Info

Start Date :

July 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2007

Estimated Enrollment :

18 Patients enrolled

Trial Details

Trial ID

NCT00806078

Start Date

July 1 2007

End Date

August 1 2007

Last Update

August 31 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

MDS Pharma Services

Saint Laurent, Montreal, Quebec, Canada, H4R 2N6